chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Alcohol test negative, Blood creatinine increased, Blood sodium increased, Blood thyroid stimulating hormone normal
Clinical narrative: Clinical Summary Patient is a 82 y.o. male with a history of lung cancer and OSA who presented to hospital 12/1/2022 unresponsive. Required intubation and found to have multifocal PNA. Hospitalist consulted to assume care out of ICU. Course complicated by acute encephalopathy and dysphagia. Care transitioned to DNRCC 12/13/2022. Hospital course complicated by need for insurance application. Patient passed 12/24/2022.    1. GOC: transitioned to comfort care on 12/13/22 with hospice measures. Patient passed 12/24/2022.  2. Acute metabolic encephalopathy:  H/o dementia (on donepezil), but lives independently and performs all ADLs per son. Found unresponsive at home 12/1/22, last known well 11/29/22, GCS 7 on admit. EtOH, UDS, urine cultures, TSH negative. CT imaging on admit non-acute. MRI brain without 12/3/22 non-acute. Patient does not follow commands for neuro exam. Neurology followed.  3. Hypernatremia: Na 156 on 12/4/22. Not further lab work given DNR CC.  4. Community acquired pneumonia: With sepsis on admit. Positive for COVID-19, influenza, and strep pneumoniae on admit. Decadron given 12/1-12/4, stopped d/t worsening mental status. S/p rocephin and tamiflu. Isolation removed 12/12/2022 5. AKI: Baseline creatinine 1.0, creat 2.91 on admit, suspected d/t rhabdomyolysis. Resolved.  6. Hyperkalemia: s/p medical management. No further tx given plan for DNRCC 7. Dysphagia: NGT removed 12/12/2022. Palliative followed 8. Sacral and upper back wounds:  both POA and unstagable pressure ulcers. Wound care followed  9. Cervical stenosis: CT C-spine with severe C3-4 foraminal stenosis. MRI C-spine not tolerated d/t intubation. Trauma followed 10. Parkinson disease: Recent diagnosis. Has right pill rolling tremor.  11. Lung cancer: Completed treatment 2009. S/p left upper lobectomy, chemotherapy and radiation. No history of recurrence. 12. Code status: DNR-CC changed 12/13/2022 per palliative
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Computerised tomogram spine, Culture urine negative, Death, Decubitus ulcer
Clinical narrative: Clinical Summary Patient is a 82 y.o. male with a history of lung cancer and OSA who presented to hospital 12/1/2022 unresponsive. Required intubation and found to have multifocal PNA. Hospitalist consulted to assume care out of ICU. Course complicated by acute encephalopathy and dysphagia. Care transitioned to DNRCC 12/13/2022. Hospital course complicated by need for insurance application. Patient passed 12/24/2022.    1. GOC: transitioned to comfort care on 12/13/22 with hospice measures. Patient passed 12/24/2022.  2. Acute metabolic encephalopathy:  H/o dementia (on donepezil), but lives independently and performs all ADLs per son. Found unresponsive at home 12/1/22, last known well 11/29/22, GCS 7 on admit. EtOH, UDS, urine cultures, TSH negative. CT imaging on admit non-acute. MRI brain without 12/3/22 non-acute. Patient does not follow commands for neuro exam. Neurology followed.  3. Hypernatremia: Na 156 on 12/4/22. Not further lab work given DNR CC.  4. Community acquired pneumonia: With sepsis on admit. Positive for COVID-19, influenza, and strep pneumoniae on admit. Decadron given 12/1-12/4, stopped d/t worsening mental status. S/p rocephin and tamiflu. Isolation removed 12/12/2022 5. AKI: Baseline creatinine 1.0, creat 2.91 on admit, suspected d/t rhabdomyolysis. Resolved.  6. Hyperkalemia: s/p medical management. No further tx given plan for DNRCC 7. Dysphagia: NGT removed 12/12/2022. Palliative followed 8. Sacral and upper back wounds:  both POA and unstagable pressure ulcers. Wound care followed  9. Cervical stenosis: CT C-spine with severe C3-4 foraminal stenosis. MRI C-spine not tolerated d/t intubation. Trauma followed 10. Parkinson disease: Recent diagnosis. Has right pill rolling tremor.  11. Lung cancer: Completed treatment 2009. S/p left upper lobectomy, chemotherapy and radiation. No history of recurrence. 12. Code status: DNR-CC changed 12/13/2022 per palliative
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Drug screen negative, Dysphagia, Encephalopathy, Endotracheal intubation, Gastrointestinal tube insertion
Clinical narrative: Clinical Summary Patient is a 82 y.o. male with a history of lung cancer and OSA who presented to hospital 12/1/2022 unresponsive. Required intubation and found to have multifocal PNA. Hospitalist consulted to assume care out of ICU. Course complicated by acute encephalopathy and dysphagia. Care transitioned to DNRCC 12/13/2022. Hospital course complicated by need for insurance application. Patient passed 12/24/2022.    1. GOC: transitioned to comfort care on 12/13/22 with hospice measures. Patient passed 12/24/2022.  2. Acute metabolic encephalopathy:  H/o dementia (on donepezil), but lives independently and performs all ADLs per son. Found unresponsive at home 12/1/22, last known well 11/29/22, GCS 7 on admit. EtOH, UDS, urine cultures, TSH negative. CT imaging on admit non-acute. MRI brain without 12/3/22 non-acute. Patient does not follow commands for neuro exam. Neurology followed.  3. Hypernatremia: Na 156 on 12/4/22. Not further lab work given DNR CC.  4. Community acquired pneumonia: With sepsis on admit. Positive for COVID-19, influenza, and strep pneumoniae on admit. Decadron given 12/1-12/4, stopped d/t worsening mental status. S/p rocephin and tamiflu. Isolation removed 12/12/2022 5. AKI: Baseline creatinine 1.0, creat 2.91 on admit, suspected d/t rhabdomyolysis. Resolved.  6. Hyperkalemia: s/p medical management. No further tx given plan for DNRCC 7. Dysphagia: NGT removed 12/12/2022. Palliative followed 8. Sacral and upper back wounds:  both POA and unstagable pressure ulcers. Wound care followed  9. Cervical stenosis: CT C-spine with severe C3-4 foraminal stenosis. MRI C-spine not tolerated d/t intubation. Trauma followed 10. Parkinson disease: Recent diagnosis. Has right pill rolling tremor.  11. Lung cancer: Completed treatment 2009. S/p left upper lobectomy, chemotherapy and radiation. No history of recurrence. 12. Code status: DNR-CC changed 12/13/2022 per palliative
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperkalaemia, Hypernatraemia, Influenza virus test positive, Intensive care, Magnetic resonance imaging head normal
Clinical narrative: Clinical Summary Patient is a 82 y.o. male with a history of lung cancer and OSA who presented to hospital 12/1/2022 unresponsive. Required intubation and found to have multifocal PNA. Hospitalist consulted to assume care out of ICU. Course complicated by acute encephalopathy and dysphagia. Care transitioned to DNRCC 12/13/2022. Hospital course complicated by need for insurance application. Patient passed 12/24/2022.    1. GOC: transitioned to comfort care on 12/13/22 with hospice measures. Patient passed 12/24/2022.  2. Acute metabolic encephalopathy:  H/o dementia (on donepezil), but lives independently and performs all ADLs per son. Found unresponsive at home 12/1/22, last known well 11/29/22, GCS 7 on admit. EtOH, UDS, urine cultures, TSH negative. CT imaging on admit non-acute. MRI brain without 12/3/22 non-acute. Patient does not follow commands for neuro exam. Neurology followed.  3. Hypernatremia: Na 156 on 12/4/22. Not further lab work given DNR CC.  4. Community acquired pneumonia: With sepsis on admit. Positive for COVID-19, influenza, and strep pneumoniae on admit. Decadron given 12/1-12/4, stopped d/t worsening mental status. S/p rocephin and tamiflu. Isolation removed 12/12/2022 5. AKI: Baseline creatinine 1.0, creat 2.91 on admit, suspected d/t rhabdomyolysis. Resolved.  6. Hyperkalemia: s/p medical management. No further tx given plan for DNRCC 7. Dysphagia: NGT removed 12/12/2022. Palliative followed 8. Sacral and upper back wounds:  both POA and unstagable pressure ulcers. Wound care followed  9. Cervical stenosis: CT C-spine with severe C3-4 foraminal stenosis. MRI C-spine not tolerated d/t intubation. Trauma followed 10. Parkinson disease: Recent diagnosis. Has right pill rolling tremor.  11. Lung cancer: Completed treatment 2009. S/p left upper lobectomy, chemotherapy and radiation. No history of recurrence. 12. Code status: DNR-CC changed 12/13/2022 per palliative
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Mental status changes, Metabolic encephalopathy, Parkinson's disease, Pneumonia, Rhabdomyolysis
Clinical narrative: Clinical Summary Patient is a 82 y.o. male with a history of lung cancer and OSA who presented to hospital 12/1/2022 unresponsive. Required intubation and found to have multifocal PNA. Hospitalist consulted to assume care out of ICU. Course complicated by acute encephalopathy and dysphagia. Care transitioned to DNRCC 12/13/2022. Hospital course complicated by need for insurance application. Patient passed 12/24/2022.    1. GOC: transitioned to comfort care on 12/13/22 with hospice measures. Patient passed 12/24/2022.  2. Acute metabolic encephalopathy:  H/o dementia (on donepezil), but lives independently and performs all ADLs per son. Found unresponsive at home 12/1/22, last known well 11/29/22, GCS 7 on admit. EtOH, UDS, urine cultures, TSH negative. CT imaging on admit non-acute. MRI brain without 12/3/22 non-acute. Patient does not follow commands for neuro exam. Neurology followed.  3. Hypernatremia: Na 156 on 12/4/22. Not further lab work given DNR CC.  4. Community acquired pneumonia: With sepsis on admit. Positive for COVID-19, influenza, and strep pneumoniae on admit. Decadron given 12/1-12/4, stopped d/t worsening mental status. S/p rocephin and tamiflu. Isolation removed 12/12/2022 5. AKI: Baseline creatinine 1.0, creat 2.91 on admit, suspected d/t rhabdomyolysis. Resolved.  6. Hyperkalemia: s/p medical management. No further tx given plan for DNRCC 7. Dysphagia: NGT removed 12/12/2022. Palliative followed 8. Sacral and upper back wounds:  both POA and unstagable pressure ulcers. Wound care followed  9. Cervical stenosis: CT C-spine with severe C3-4 foraminal stenosis. MRI C-spine not tolerated d/t intubation. Trauma followed 10. Parkinson disease: Recent diagnosis. Has right pill rolling tremor.  11. Lung cancer: Completed treatment 2009. S/p left upper lobectomy, chemotherapy and radiation. No history of recurrence. 12. Code status: DNR-CC changed 12/13/2022 per palliative
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Streptococcus test positive, Tremor, Unresponsive to stimuli
Clinical narrative: Clinical Summary Patient is a 82 y.o. male with a history of lung cancer and OSA who presented to hospital 12/1/2022 unresponsive. Required intubation and found to have multifocal PNA. Hospitalist consulted to assume care out of ICU. Course complicated by acute encephalopathy and dysphagia. Care transitioned to DNRCC 12/13/2022. Hospital course complicated by need for insurance application. Patient passed 12/24/2022.    1. GOC: transitioned to comfort care on 12/13/22 with hospice measures. Patient passed 12/24/2022.  2. Acute metabolic encephalopathy:  H/o dementia (on donepezil), but lives independently and performs all ADLs per son. Found unresponsive at home 12/1/22, last known well 11/29/22, GCS 7 on admit. EtOH, UDS, urine cultures, TSH negative. CT imaging on admit non-acute. MRI brain without 12/3/22 non-acute. Patient does not follow commands for neuro exam. Neurology followed.  3. Hypernatremia: Na 156 on 12/4/22. Not further lab work given DNR CC.  4. Community acquired pneumonia: With sepsis on admit. Positive for COVID-19, influenza, and strep pneumoniae on admit. Decadron given 12/1-12/4, stopped d/t worsening mental status. S/p rocephin and tamiflu. Isolation removed 12/12/2022 5. AKI: Baseline creatinine 1.0, creat 2.91 on admit, suspected d/t rhabdomyolysis. Resolved.  6. Hyperkalemia: s/p medical management. No further tx given plan for DNRCC 7. Dysphagia: NGT removed 12/12/2022. Palliative followed 8. Sacral and upper back wounds:  both POA and unstagable pressure ulcers. Wound care followed  9. Cervical stenosis: CT C-spine with severe C3-4 foraminal stenosis. MRI C-spine not tolerated d/t intubation. Trauma followed 10. Parkinson disease: Recent diagnosis. Has right pill rolling tremor.  11. Lung cancer: Completed treatment 2009. S/p left upper lobectomy, chemotherapy and radiation. No history of recurrence. 12. Code status: DNR-CC changed 12/13/2022 per palliative
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Vertebral foraminal stenosis
Clinical narrative: Clinical Summary Patient is a 82 y.o. male with a history of lung cancer and OSA who presented to hospital 12/1/2022 unresponsive. Required intubation and found to have multifocal PNA. Hospitalist consulted to assume care out of ICU. Course complicated by acute encephalopathy and dysphagia. Care transitioned to DNRCC 12/13/2022. Hospital course complicated by need for insurance application. Patient passed 12/24/2022.    1. GOC: transitioned to comfort care on 12/13/22 with hospice measures. Patient passed 12/24/2022.  2. Acute metabolic encephalopathy:  H/o dementia (on donepezil), but lives independently and performs all ADLs per son. Found unresponsive at home 12/1/22, last known well 11/29/22, GCS 7 on admit. EtOH, UDS, urine cultures, TSH negative. CT imaging on admit non-acute. MRI brain without 12/3/22 non-acute. Patient does not follow commands for neuro exam. Neurology followed.  3. Hypernatremia: Na 156 on 12/4/22. Not further lab work given DNR CC.  4. Community acquired pneumonia: With sepsis on admit. Positive for COVID-19, influenza, and strep pneumoniae on admit. Decadron given 12/1-12/4, stopped d/t worsening mental status. S/p rocephin and tamiflu. Isolation removed 12/12/2022 5. AKI: Baseline creatinine 1.0, creat 2.91 on admit, suspected d/t rhabdomyolysis. Resolved.  6. Hyperkalemia: s/p medical management. No further tx given plan for DNRCC 7. Dysphagia: NGT removed 12/12/2022. Palliative followed 8. Sacral and upper back wounds:  both POA and unstagable pressure ulcers. Wound care followed  9. Cervical stenosis: CT C-spine with severe C3-4 foraminal stenosis. MRI C-spine not tolerated d/t intubation. Trauma followed 10. Parkinson disease: Recent diagnosis. Has right pill rolling tremor.  11. Lung cancer: Completed treatment 2009. S/p left upper lobectomy, chemotherapy and radiation. No history of recurrence. 12. Code status: DNR-CC changed 12/13/2022 per palliative
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: during our covid site visit from DOH on 12.15.22, it was discovered that we had a pfizer batch in the frig past BUD date. During the DOH investigation they went back through all the covid injections that were given and saw this patients lot number was given past BUD date. patient has been contacted and revaccination was offered. manufacture was notified and reports were filed pending outcome.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Dehydration, Diarrhoea, SARS-CoV-2 test positive, Spinal operation
Clinical narrative: 12/15/22 presents to ED for "diarrhea with dehydration". PMHx of "anemia, anxiety, thyroid cancer, chronic back pain, chronic renal failure, diabetes mellitus, hypertension, who underwent lumbar surgery initially on 11/7/2022"
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Anticoagulant therapy, Blood creatinine decreased, Blood sodium increased
Clinical narrative: Patient is a 67 y.o. female with history of atrial fibrillation, asthma, hfpef, t2dm, ckd, restless legs presented to Hospital with shortness of breath and fever .   Acute hypoxic respiratory failure d/t - resolved COVID-19 pneumonia HFpEF not in exacerbation P/w 1 week history of worsening SB found to be Covid+. Afebrile on arrival, HR 88, RR 20, BP 149/61, satting 92% on 2L by NC BNP >4K Appears dry despite BNP Initial CBC w no leukocytosis CXR: cardiomegaly, CHF-like findings CTA: no PE. Consitent with multifocal pneumonia. Pleural effusion R>L Cont supplemental O2 to maintain goal SpO2 > 88-90% Consider remdesivir pending serial labs given CKD. CrCl remains <30   Obtain baseline inflammatory markers Start Home bumex tmw for dry lung strategy  monitor I&Os Encourage IS use Contact precautions end isolation 12/30 PT recs HH therapy SW for discharge needs Back to baseline RA Continue Albuterol, robitussin-DM, tylenol PRN Continue Decadron 6mg PO daily for 10 days  Continue xeralto Follow up with pcp   Hypernatremia - resolved Na 147 initial Likely from poor oral intake Improving to 146 Continue to monitor   CKD stage 3b Anemia of Chronic Disease Cr 1.62 initial (baseline 1.5-1.7) Hgb at baseline Monitor  Continue home iron supplement Follow up with pcp  HTN Atrial Fib Continue xeralto, BB, plavix, statin   T2DM - well-controlled A1c 6.2 Hold home med ISS and accuchecks while here   Morbid Obesity  OSA Body mass index is 49.09 kg/m². Discussed dietary and lifestyle modifications Consider nutrition consult  Wears CPAP at times but not every night. Says she doesn't know where it is at home
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, COVID-19, COVID-19 pneumonia, Cardiac failure congestive, Cardiomegaly
Clinical narrative: Patient is a 67 y.o. female with history of atrial fibrillation, asthma, hfpef, t2dm, ckd, restless legs presented to Hospital with shortness of breath and fever .   Acute hypoxic respiratory failure d/t - resolved COVID-19 pneumonia HFpEF not in exacerbation P/w 1 week history of worsening SB found to be Covid+. Afebrile on arrival, HR 88, RR 20, BP 149/61, satting 92% on 2L by NC BNP >4K Appears dry despite BNP Initial CBC w no leukocytosis CXR: cardiomegaly, CHF-like findings CTA: no PE. Consitent with multifocal pneumonia. Pleural effusion R>L Cont supplemental O2 to maintain goal SpO2 > 88-90% Consider remdesivir pending serial labs given CKD. CrCl remains <30   Obtain baseline inflammatory markers Start Home bumex tmw for dry lung strategy  monitor I&Os Encourage IS use Contact precautions end isolation 12/30 PT recs HH therapy SW for discharge needs Back to baseline RA Continue Albuterol, robitussin-DM, tylenol PRN Continue Decadron 6mg PO daily for 10 days  Continue xeralto Follow up with pcp   Hypernatremia - resolved Na 147 initial Likely from poor oral intake Improving to 146 Continue to monitor   CKD stage 3b Anemia of Chronic Disease Cr 1.62 initial (baseline 1.5-1.7) Hgb at baseline Monitor  Continue home iron supplement Follow up with pcp  HTN Atrial Fib Continue xeralto, BB, plavix, statin   T2DM - well-controlled A1c 6.2 Hold home med ISS and accuchecks while here   Morbid Obesity  OSA Body mass index is 49.09 kg/m². Discussed dietary and lifestyle modifications Consider nutrition consult  Wears CPAP at times but not every night. Says she doesn't know where it is at home
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Dyspnoea, Full blood count normal, Glycosylated haemoglobin normal, Hypernatraemia
Clinical narrative: Patient is a 67 y.o. female with history of atrial fibrillation, asthma, hfpef, t2dm, ckd, restless legs presented to Hospital with shortness of breath and fever .   Acute hypoxic respiratory failure d/t - resolved COVID-19 pneumonia HFpEF not in exacerbation P/w 1 week history of worsening SB found to be Covid+. Afebrile on arrival, HR 88, RR 20, BP 149/61, satting 92% on 2L by NC BNP >4K Appears dry despite BNP Initial CBC w no leukocytosis CXR: cardiomegaly, CHF-like findings CTA: no PE. Consitent with multifocal pneumonia. Pleural effusion R>L Cont supplemental O2 to maintain goal SpO2 > 88-90% Consider remdesivir pending serial labs given CKD. CrCl remains <30   Obtain baseline inflammatory markers Start Home bumex tmw for dry lung strategy  monitor I&Os Encourage IS use Contact precautions end isolation 12/30 PT recs HH therapy SW for discharge needs Back to baseline RA Continue Albuterol, robitussin-DM, tylenol PRN Continue Decadron 6mg PO daily for 10 days  Continue xeralto Follow up with pcp   Hypernatremia - resolved Na 147 initial Likely from poor oral intake Improving to 146 Continue to monitor   CKD stage 3b Anemia of Chronic Disease Cr 1.62 initial (baseline 1.5-1.7) Hgb at baseline Monitor  Continue home iron supplement Follow up with pcp  HTN Atrial Fib Continue xeralto, BB, plavix, statin   T2DM - well-controlled A1c 6.2 Hold home med ISS and accuchecks while here   Morbid Obesity  OSA Body mass index is 49.09 kg/m². Discussed dietary and lifestyle modifications Consider nutrition consult  Wears CPAP at times but not every night. Says she doesn't know where it is at home
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Hypophagia, Pleural effusion, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient is a 67 y.o. female with history of atrial fibrillation, asthma, hfpef, t2dm, ckd, restless legs presented to Hospital with shortness of breath and fever .   Acute hypoxic respiratory failure d/t - resolved COVID-19 pneumonia HFpEF not in exacerbation P/w 1 week history of worsening SB found to be Covid+. Afebrile on arrival, HR 88, RR 20, BP 149/61, satting 92% on 2L by NC BNP >4K Appears dry despite BNP Initial CBC w no leukocytosis CXR: cardiomegaly, CHF-like findings CTA: no PE. Consitent with multifocal pneumonia. Pleural effusion R>L Cont supplemental O2 to maintain goal SpO2 > 88-90% Consider remdesivir pending serial labs given CKD. CrCl remains <30   Obtain baseline inflammatory markers Start Home bumex tmw for dry lung strategy  monitor I&Os Encourage IS use Contact precautions end isolation 12/30 PT recs HH therapy SW for discharge needs Back to baseline RA Continue Albuterol, robitussin-DM, tylenol PRN Continue Decadron 6mg PO daily for 10 days  Continue xeralto Follow up with pcp   Hypernatremia - resolved Na 147 initial Likely from poor oral intake Improving to 146 Continue to monitor   CKD stage 3b Anemia of Chronic Disease Cr 1.62 initial (baseline 1.5-1.7) Hgb at baseline Monitor  Continue home iron supplement Follow up with pcp  HTN Atrial Fib Continue xeralto, BB, plavix, statin   T2DM - well-controlled A1c 6.2 Hold home med ISS and accuchecks while here   Morbid Obesity  OSA Body mass index is 49.09 kg/m². Discussed dietary and lifestyle modifications Consider nutrition consult  Wears CPAP at times but not every night. Says she doesn't know where it is at home
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Penile swelling
Clinical narrative: Penile swelling. Resolved after 5 days without intervention.  Alternative vaccine schedule per parent request.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Pfizer bivalent booster(GK1657)  was ordered as dose #3. Original pfizer vaccine was given instead (GD1857). Mom was notified of vaccine event and advised to monitor for any adverse effects and call back with further questions.
Age: 48.0
Sex: F
Vaccine: COVID19-2
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: I felt ok the day after receiving the vaccine. On 12/29/2022 my lymph nodes under my left armpit began to swell and hurt. I used only hot compress to relieve the pain. I had these symptoms for two days.
Age: 69.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Arthralgia, COVID-19, Diarrhoea, Gastrointestinal disorder, Oropharyngeal pain
Clinical narrative: I had symptoms of a fever, a sore throat, body aches and joint pain on 12/27/2022. I tested myself at home and the result was positive on 12/28/2022. I reached out to my PCP and he called in Paxlovid for me. I started to take the medication right away. My whole GI tract seemed to become affected and I was experiencing diarrhea. It also seemed that my skin started to shed as well. I feel that I have recovered from COVID as of today, 01/12/2023.
Age: 69.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive, Skin exfoliation
Clinical narrative: I had symptoms of a fever, a sore throat, body aches and joint pain on 12/27/2022. I tested myself at home and the result was positive on 12/28/2022. I reached out to my PCP and he called in Paxlovid for me. I started to take the medication right away. My whole GI tract seemed to become affected and I was experiencing diarrhea. It also seemed that my skin started to shed as well. I feel that I have recovered from COVID as of today, 01/12/2023.
Age: 1.5
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative
Clinical narrative: She had a fever and was tugging at her ears. She was also very congested. I contacted her doctor and he prescribed cefdinir. She is still dealing with these symptoms at this time.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was to receive the Pfizer Bivalent and received the Monovalent instead. Patient is doing well, had no adverse events, no symptoms and did not need any medical attention.
Age: 2.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Bivalent booster given as dose #2 instead of second dose of monovalent to complete primary series.  No adverse reactions
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary normal, Asthenia, Atelectasis, COVID-19
Clinical narrative: Patient is a 74 y.o. male patient of CNP with history of hypertension, hyperlipidemia, BPH s/p prostate cancer, hypothyroidism, Lewy body dementia presented with severe confusion found to be COVID-positive and febrile.  Confusion likely metabolic encephalopathy due to acute viral infection.  Completed course of remdesivir and received a course of Decadron with improvement of respiratory symptoms.  To be discharged to SNF.   Acute metabolic encephalopathy suspect due to COVID-19 Virus Infection with viral pneumonia  Febrile 102.1 on admission Date of onset of symptoms: unclear though believed to be about a week ago Symptoms present on admission: severe confusion and mental decline, severe weakness, and frequent falls Initially on room air however became hypoxic shortly after admission Date of covid positive test: 12/16/2022 Vaccination status: vaccinated Imaging: Chest x-ray mild right basilar atelectasis CT head - no acute intracranial abnormality; CT cervical spine - no injury Oxygen requirements on admission: None Current oxygen requirements: RA with sats 93-94%. 96% on 2 L. Requires oxygen at night Medical therapy: completed remdesivir, IV Lasix 20 mg daily x3 for dry lung strategy. Patient received 7 days of decadron. He has been having progressive worsening confusion. Will discontinue steroids, should that be contributing to his confusion.  Consultants following: infectious disease Completed 5 days of abx Anticipated special isolation end date:12/26/2022  CT angiogram of the lungs was done which ruled out any pulmonary embolism     Acute hypoxic respiratory failure - secondary to covid - improving with decreased oxygen requirements   Lewy body dementia with anxiety Hard of hearing Patient uses hearing aids  Rns informed of communication barrier Per daughter, patient's memory is usually sharp and his dementia Continue Zoloft and Exelon Worsened due to underlying COVID infection.   Frequent falls S/p scalp trauma Patient with fall 12/14 prompting ER eval and again with repeat fall earlier today Usually ambulates with use of a walker and able to participate with PT Currently at assisted living for ST and PT which he usually is able to participate with  PT/OT, speech consulted   Hyponatremia due to dehydration and possibly due to  Diarrhea: Resolved Anemia, chronic OSA not on CPAP  HTN, essential Hyperlipidemia Hypothyroidism:Continue atorvastatin, levothyroxine, metoprolol  BPH s/p prostate cancer Continue tamsulosin PSA screening MRI brain given sudden onset confusion which is normal
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Computerised tomogram head normal, Computerised tomogram spine, Confusional state, Dehydration
Clinical narrative: Patient is a 74 y.o. male patient of CNP with history of hypertension, hyperlipidemia, BPH s/p prostate cancer, hypothyroidism, Lewy body dementia presented with severe confusion found to be COVID-positive and febrile.  Confusion likely metabolic encephalopathy due to acute viral infection.  Completed course of remdesivir and received a course of Decadron with improvement of respiratory symptoms.  To be discharged to SNF.   Acute metabolic encephalopathy suspect due to COVID-19 Virus Infection with viral pneumonia  Febrile 102.1 on admission Date of onset of symptoms: unclear though believed to be about a week ago Symptoms present on admission: severe confusion and mental decline, severe weakness, and frequent falls Initially on room air however became hypoxic shortly after admission Date of covid positive test: 12/16/2022 Vaccination status: vaccinated Imaging: Chest x-ray mild right basilar atelectasis CT head - no acute intracranial abnormality; CT cervical spine - no injury Oxygen requirements on admission: None Current oxygen requirements: RA with sats 93-94%. 96% on 2 L. Requires oxygen at night Medical therapy: completed remdesivir, IV Lasix 20 mg daily x3 for dry lung strategy. Patient received 7 days of decadron. He has been having progressive worsening confusion. Will discontinue steroids, should that be contributing to his confusion.  Consultants following: infectious disease Completed 5 days of abx Anticipated special isolation end date:12/26/2022  CT angiogram of the lungs was done which ruled out any pulmonary embolism     Acute hypoxic respiratory failure - secondary to covid - improving with decreased oxygen requirements   Lewy body dementia with anxiety Hard of hearing Patient uses hearing aids  Rns informed of communication barrier Per daughter, patient's memory is usually sharp and his dementia Continue Zoloft and Exelon Worsened due to underlying COVID infection.   Frequent falls S/p scalp trauma Patient with fall 12/14 prompting ER eval and again with repeat fall earlier today Usually ambulates with use of a walker and able to participate with PT Currently at assisted living for ST and PT which he usually is able to participate with  PT/OT, speech consulted   Hyponatremia due to dehydration and possibly due to  Diarrhea: Resolved Anemia, chronic OSA not on CPAP  HTN, essential Hyperlipidemia Hypothyroidism:Continue atorvastatin, levothyroxine, metoprolol  BPH s/p prostate cancer Continue tamsulosin PSA screening MRI brain given sudden onset confusion which is normal
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fall, Hyponatraemia, Hypoxia, Magnetic resonance imaging head normal
Clinical narrative: Patient is a 74 y.o. male patient of CNP with history of hypertension, hyperlipidemia, BPH s/p prostate cancer, hypothyroidism, Lewy body dementia presented with severe confusion found to be COVID-positive and febrile.  Confusion likely metabolic encephalopathy due to acute viral infection.  Completed course of remdesivir and received a course of Decadron with improvement of respiratory symptoms.  To be discharged to SNF.   Acute metabolic encephalopathy suspect due to COVID-19 Virus Infection with viral pneumonia  Febrile 102.1 on admission Date of onset of symptoms: unclear though believed to be about a week ago Symptoms present on admission: severe confusion and mental decline, severe weakness, and frequent falls Initially on room air however became hypoxic shortly after admission Date of covid positive test: 12/16/2022 Vaccination status: vaccinated Imaging: Chest x-ray mild right basilar atelectasis CT head - no acute intracranial abnormality; CT cervical spine - no injury Oxygen requirements on admission: None Current oxygen requirements: RA with sats 93-94%. 96% on 2 L. Requires oxygen at night Medical therapy: completed remdesivir, IV Lasix 20 mg daily x3 for dry lung strategy. Patient received 7 days of decadron. He has been having progressive worsening confusion. Will discontinue steroids, should that be contributing to his confusion.  Consultants following: infectious disease Completed 5 days of abx Anticipated special isolation end date:12/26/2022  CT angiogram of the lungs was done which ruled out any pulmonary embolism     Acute hypoxic respiratory failure - secondary to covid - improving with decreased oxygen requirements   Lewy body dementia with anxiety Hard of hearing Patient uses hearing aids  Rns informed of communication barrier Per daughter, patient's memory is usually sharp and his dementia Continue Zoloft and Exelon Worsened due to underlying COVID infection.   Frequent falls S/p scalp trauma Patient with fall 12/14 prompting ER eval and again with repeat fall earlier today Usually ambulates with use of a walker and able to participate with PT Currently at assisted living for ST and PT which he usually is able to participate with  PT/OT, speech consulted   Hyponatremia due to dehydration and possibly due to  Diarrhea: Resolved Anemia, chronic OSA not on CPAP  HTN, essential Hyperlipidemia Hypothyroidism:Continue atorvastatin, levothyroxine, metoprolol  BPH s/p prostate cancer Continue tamsulosin PSA screening MRI brain given sudden onset confusion which is normal
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Mental status changes, Metabolic encephalopathy, Pneumonia viral, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient is a 74 y.o. male patient of CNP with history of hypertension, hyperlipidemia, BPH s/p prostate cancer, hypothyroidism, Lewy body dementia presented with severe confusion found to be COVID-positive and febrile.  Confusion likely metabolic encephalopathy due to acute viral infection.  Completed course of remdesivir and received a course of Decadron with improvement of respiratory symptoms.  To be discharged to SNF.   Acute metabolic encephalopathy suspect due to COVID-19 Virus Infection with viral pneumonia  Febrile 102.1 on admission Date of onset of symptoms: unclear though believed to be about a week ago Symptoms present on admission: severe confusion and mental decline, severe weakness, and frequent falls Initially on room air however became hypoxic shortly after admission Date of covid positive test: 12/16/2022 Vaccination status: vaccinated Imaging: Chest x-ray mild right basilar atelectasis CT head - no acute intracranial abnormality; CT cervical spine - no injury Oxygen requirements on admission: None Current oxygen requirements: RA with sats 93-94%. 96% on 2 L. Requires oxygen at night Medical therapy: completed remdesivir, IV Lasix 20 mg daily x3 for dry lung strategy. Patient received 7 days of decadron. He has been having progressive worsening confusion. Will discontinue steroids, should that be contributing to his confusion.  Consultants following: infectious disease Completed 5 days of abx Anticipated special isolation end date:12/26/2022  CT angiogram of the lungs was done which ruled out any pulmonary embolism     Acute hypoxic respiratory failure - secondary to covid - improving with decreased oxygen requirements   Lewy body dementia with anxiety Hard of hearing Patient uses hearing aids  Rns informed of communication barrier Per daughter, patient's memory is usually sharp and his dementia Continue Zoloft and Exelon Worsened due to underlying COVID infection.   Frequent falls S/p scalp trauma Patient with fall 12/14 prompting ER eval and again with repeat fall earlier today Usually ambulates with use of a walker and able to participate with PT Currently at assisted living for ST and PT which he usually is able to participate with  PT/OT, speech consulted   Hyponatremia due to dehydration and possibly due to  Diarrhea: Resolved Anemia, chronic OSA not on CPAP  HTN, essential Hyperlipidemia Hypothyroidism:Continue atorvastatin, levothyroxine, metoprolol  BPH s/p prostate cancer Continue tamsulosin PSA screening MRI brain given sudden onset confusion which is normal
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Skin injury, Viral infection
Clinical narrative: Patient is a 74 y.o. male patient of CNP with history of hypertension, hyperlipidemia, BPH s/p prostate cancer, hypothyroidism, Lewy body dementia presented with severe confusion found to be COVID-positive and febrile.  Confusion likely metabolic encephalopathy due to acute viral infection.  Completed course of remdesivir and received a course of Decadron with improvement of respiratory symptoms.  To be discharged to SNF.   Acute metabolic encephalopathy suspect due to COVID-19 Virus Infection with viral pneumonia  Febrile 102.1 on admission Date of onset of symptoms: unclear though believed to be about a week ago Symptoms present on admission: severe confusion and mental decline, severe weakness, and frequent falls Initially on room air however became hypoxic shortly after admission Date of covid positive test: 12/16/2022 Vaccination status: vaccinated Imaging: Chest x-ray mild right basilar atelectasis CT head - no acute intracranial abnormality; CT cervical spine - no injury Oxygen requirements on admission: None Current oxygen requirements: RA with sats 93-94%. 96% on 2 L. Requires oxygen at night Medical therapy: completed remdesivir, IV Lasix 20 mg daily x3 for dry lung strategy. Patient received 7 days of decadron. He has been having progressive worsening confusion. Will discontinue steroids, should that be contributing to his confusion.  Consultants following: infectious disease Completed 5 days of abx Anticipated special isolation end date:12/26/2022  CT angiogram of the lungs was done which ruled out any pulmonary embolism     Acute hypoxic respiratory failure - secondary to covid - improving with decreased oxygen requirements   Lewy body dementia with anxiety Hard of hearing Patient uses hearing aids  Rns informed of communication barrier Per daughter, patient's memory is usually sharp and his dementia Continue Zoloft and Exelon Worsened due to underlying COVID infection.   Frequent falls S/p scalp trauma Patient with fall 12/14 prompting ER eval and again with repeat fall earlier today Usually ambulates with use of a walker and able to participate with PT Currently at assisted living for ST and PT which he usually is able to participate with  PT/OT, speech consulted   Hyponatremia due to dehydration and possibly due to  Diarrhea: Resolved Anemia, chronic OSA not on CPAP  HTN, essential Hyperlipidemia Hypothyroidism:Continue atorvastatin, levothyroxine, metoprolol  BPH s/p prostate cancer Continue tamsulosin PSA screening MRI brain given sudden onset confusion which is normal
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case. Moderna 3/24/21 047A21A, 4/21/21 040B21A and boosted Pfizer 2/11/22 FD2718, 11/4/22 GJ3275
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: during our covid site visit on 12.15.22, it was discovered that we had a pfizer batch in the frig past BUD date. During the investigation they went back through all the covid injections that were given and saw this patients lot number was given past BUD date. patient has been contacted and revaccination was offered. manufacture was notified and reports were filed pending outcome.
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Bivalent booster given as dose #2
Age: 83.0
Sex: M
Vaccine: UNK
Symptoms: Cerebral haemorrhage, Computerised tomogram head abnormal, Haemorrhagic stroke, Headache, Platelet count decreased
Clinical narrative: Headache following booster for 2 days. Found to have thrombocytopenia and hemorrhagic stroke when presenting to the ER 2 days after vaccine.
Age: 83.0
Sex: M
Vaccine: UNK
Symptoms: Subarachnoid haemorrhage, Thrombocytopenia
Clinical narrative: Headache following booster for 2 days. Found to have thrombocytopenia and hemorrhagic stroke when presenting to the ER 2 days after vaccine.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Ammonia normal, Blood creatinine increased, COVID-19, COVID-19 pneumonia, Cerebrovascular accident
Clinical narrative: Patient is a 83 y.o. female with a history of CAD, prior stroke 06/2022, DM2 who presented to RMH 12/21/2022 with 2 days of progressive lethargy, confusion and poor oral intake. Work up  in ED with +ve COVID test, CXR with R pleural effusions, Cr 2.8, wbc 16k lactate 1.6, NH3 34, neg UA, nonacute CT brain.  Hospital course complicated by worsening hypoxia, per family she never wanted to be intubated. Pt was treated for COVID pneumonia with possible superimposed bacterial pneumonia with dexamethasone and antibiotics, remained encephalopathic during hospital stay, on 12/23 pt with worsening shortness of breath and hypoxia on full heated high flow nasal cannula discussed with poor prognosis and patient changed to comfort care, pulmonology followed whom assessed comfort care as reasonable / appropriate.   Pt passed away peacefully on 12/26/22, 1614
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Computerised tomogram head normal, Confusional state, Death, Dyspnoea
Clinical narrative: Patient is a 83 y.o. female with a history of CAD, prior stroke 06/2022, DM2 who presented to RMH 12/21/2022 with 2 days of progressive lethargy, confusion and poor oral intake. Work up  in ED with +ve COVID test, CXR with R pleural effusions, Cr 2.8, wbc 16k lactate 1.6, NH3 34, neg UA, nonacute CT brain.  Hospital course complicated by worsening hypoxia, per family she never wanted to be intubated. Pt was treated for COVID pneumonia with possible superimposed bacterial pneumonia with dexamethasone and antibiotics, remained encephalopathic during hospital stay, on 12/23 pt with worsening shortness of breath and hypoxia on full heated high flow nasal cannula discussed with poor prognosis and patient changed to comfort care, pulmonology followed whom assessed comfort care as reasonable / appropriate.   Pt passed away peacefully on 12/26/22, 1614
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Encephalopathy, Hypophagia, Hypoxia, Lethargy, Pleural effusion
Clinical narrative: Patient is a 83 y.o. female with a history of CAD, prior stroke 06/2022, DM2 who presented to RMH 12/21/2022 with 2 days of progressive lethargy, confusion and poor oral intake. Work up  in ED with +ve COVID test, CXR with R pleural effusions, Cr 2.8, wbc 16k lactate 1.6, NH3 34, neg UA, nonacute CT brain.  Hospital course complicated by worsening hypoxia, per family she never wanted to be intubated. Pt was treated for COVID pneumonia with possible superimposed bacterial pneumonia with dexamethasone and antibiotics, remained encephalopathic during hospital stay, on 12/23 pt with worsening shortness of breath and hypoxia on full heated high flow nasal cannula discussed with poor prognosis and patient changed to comfort care, pulmonology followed whom assessed comfort care as reasonable / appropriate.   Pt passed away peacefully on 12/26/22, 1614
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Urine analysis normal, White blood cell count increased
Clinical narrative: Patient is a 83 y.o. female with a history of CAD, prior stroke 06/2022, DM2 who presented to RMH 12/21/2022 with 2 days of progressive lethargy, confusion and poor oral intake. Work up  in ED with +ve COVID test, CXR with R pleural effusions, Cr 2.8, wbc 16k lactate 1.6, NH3 34, neg UA, nonacute CT brain.  Hospital course complicated by worsening hypoxia, per family she never wanted to be intubated. Pt was treated for COVID pneumonia with possible superimposed bacterial pneumonia with dexamethasone and antibiotics, remained encephalopathic during hospital stay, on 12/23 pt with worsening shortness of breath and hypoxia on full heated high flow nasal cannula discussed with poor prognosis and patient changed to comfort care, pulmonology followed whom assessed comfort care as reasonable / appropriate.   Pt passed away peacefully on 12/26/22, 1614
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Anxiety, COVID-19, Fatigue
Clinical narrative: I tested positive for COVID-19 on June 07, 2022 my symptoms were runny nose, sneezing, extreme fatigue; loss taste and smell also suffers from anxiety.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Rhinorrhoea, SARS-CoV-2 test positive, Sneezing
Clinical narrative: I tested positive for COVID-19 on June 07, 2022 my symptoms were runny nose, sneezing, extreme fatigue; loss taste and smell also suffers from anxiety.
Age: 53.0
Sex: M
Vaccine: COVID19-2
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Pt stated that he had not received the Bivalent booster shot and last Covid vaccine was in March 2022 at his doctor's appointment. Verified by RN administering shot, later, clinical staff obtained state documentation which proved that patient had in fact already received the Bivalent booster dose in 10/2022. Second dose of Bivalent Booster administered in error based of pt's reported history.  There have been no adverse reactions reported by patient.
Age: 2.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient received Pfizer 5-11 year old COVID vaccine. Patient waited 15 minutes post injection with no adverse reactions. Vaccine administration error was not realized until patient left the office and LPN was documenting vaccine administration. Nurse manager contacted to inform mom of vaccine administration error.  Mom denied adverse reactions at time of phone call. Advised mom to continue to monitor for adverse reactions. Mom verbalized understanding.
Age: 55.0
Sex: M
Vaccine: UNK
Symptoms: Resting tremor, Tremor
Clinical narrative: Resting Tremors Left Arm and Hand
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Diarrhoea, Eye pain, Headache
Clinical narrative: My COVID-19 infection symptoms started on 01/03/2023 at 08:00PM. I had a cough, diarrhea, runny nose, post nasal drip, and slight headache in my eye socket. I did COVID-19 home test 2 times on 01/03/2023 and 01/04/2023. I wasn't sure of the result because I didn't know how to use it at the end of the COVID-19 home test. On 01/05/2023 I did another COVID-19 home test which turned out to be positive. I called my Internist on the same day when I tested positive and he prescribe me with PAXLOVID for 5 days. As of today all my symptoms are gone except the thick green mucus.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Increased viscosity of upper respiratory secretion, Malaise, Rhinorrhoea, SARS-CoV-2 test positive, Secretion discharge
Clinical narrative: My COVID-19 infection symptoms started on 01/03/2023 at 08:00PM. I had a cough, diarrhea, runny nose, post nasal drip, and slight headache in my eye socket. I did COVID-19 home test 2 times on 01/03/2023 and 01/04/2023. I wasn't sure of the result because I didn't know how to use it at the end of the COVID-19 home test. On 01/05/2023 I did another COVID-19 home test which turned out to be positive. I called my Internist on the same day when I tested positive and he prescribe me with PAXLOVID for 5 days. As of today all my symptoms are gone except the thick green mucus.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Upper-airway cough syndrome
Clinical narrative: My COVID-19 infection symptoms started on 01/03/2023 at 08:00PM. I had a cough, diarrhea, runny nose, post nasal drip, and slight headache in my eye socket. I did COVID-19 home test 2 times on 01/03/2023 and 01/04/2023. I wasn't sure of the result because I didn't know how to use it at the end of the COVID-19 home test. On 01/05/2023 I did another COVID-19 home test which turned out to be positive. I called my Internist on the same day when I tested positive and he prescribe me with PAXLOVID for 5 days. As of today all my symptoms are gone except the thick green mucus.
Age: 1.33
Sex: M
Vaccine: COVID19, DTAP, FLU4, HIBV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient received Pfizer 5-11 year old COVID vaccine. Patient waited 15 minutes post injection with no adverse reactions. Vaccine administration error was not realized until patient left the office and LPN was documenting vaccine administration. Nurse manager contacted mom to inform of vaccine administration error.  Mom denied adverse reactions at time of phone call. Advised mom to continue to monitor for adverse reactions. Mom verbalized understanding.